Skip to main content

GLP-1 Dose Conversion Chart: mg to Units

Last updated: June 2026

To convert a weekly GLP-1 dose into syringe units, divide your milligram dose by the vial concentration in mg/mL to get the volume in mL, then multiply that volume by 100 because a U-100 insulin syringe holds 100 units per mL. For example, a 0.5 mg semaglutide dose from a 2.5 mg/mL vial is 0.5 ÷ 2.5 = 0.2 mL = 20 units.

Have your vial label and target dose ready? Skip the arithmetic and get exact units instantly.

Semaglutide calculator →  ·  Tirzepatide calculator →

TL;DR — the one rule that covers every dose

  • The formula is always the same: mg ÷ (mg/mL) × 100 = units. It does not change between semaglutide and tirzepatide — only the numbers do.
  • Units depend on the vial, not the drug. The same 5 mg tirzepatide dose is 50 units from a 10 mg/mL vial but 25 units from a 20 mg/mL vial.
  • A U-100 syringe = 100 units per mL. So 1 mL is 100 units, 0.5 mL is 50 units, 0.1 mL is 10 units. That single fact is what turns mL into the line you read.
  • Always confirm against your own label. Compounded concentrations vary by pharmacy; a chart is a sanity check, never a substitute for your vial's stated mg/mL.

Why a milligram dose is not a syringe reading

Prescriptions for semaglutide and tirzepatide are written in milligrams per week — 0.25 mg, 2.5 mg, 5 mg, and so on. But an insulin syringe is not marked in milligrams. It is marked in units, and units measure volume, not mass. A unit on a U-100 syringe is one-hundredth of a millilitre. That mismatch is the entire problem this chart solves: your dose is a mass, your syringe reads a volume, and the bridge between them is the vial's concentration.

Concentration tells you how many milligrams are packed into each millilitre of liquid. A pen or branded auto-injector hides this from you because the device meters the dose. A compounded vial does not — you draw the liquid yourself, so you have to do the conversion yourself. Get the concentration wrong and every unit reading is wrong, which is why the first thing to read is never the dose, but the mg/mL printed on the vial.

How this is calculated

There are only two facts behind every number on this page, and neither is specific to GLP-1 drugs:

  1. Concentration is dose per volume. Volume needed (mL) = dose (mg) ÷ concentration (mg/mL).
  2. A U-100 syringe is 100 units per mL. Units = volume (mL) × 100.

Chain those together and you get the single rule:

units = mg ÷ (mg/mL) × 100

There is no drug-specific constant, no fudge factor, and no difference between semaglutide and tirzepatide in the maths. The molecules behave differently in your body, but on the syringe they are just a mass dissolved in a volume. Everything below is this one line applied to common doses and concentrations.

Reading units on a U-100 syringe

Before the chart, it helps to see what the units actually look like on the barrel. On a 1 mL U-100 syringe the scale runs 0 to 100; the major numbered marks are usually every 10 units, with a fine line every 1 or 2 units.

0 10 20 30 40 50 60 70 80 90 100 10u 20u 25u 50u needle

The shaded portion above marks a 50-unit (0.5 mL) draw — half the barrel. Most GLP-1 doses sit in the lower half of the syringe, between 5 and 50 units, which is why fine gradations near the start of the scale matter.

Worked examples: dose × concentration → units

Each example below is a distinct combination. Follow the same two steps every time: dose ÷ concentration = mL, then mL × 100 = units.

Example 1 — semaglutide 0.25 mg @ 2.5 mg/mL

0.25 mg ÷ 2.5 mg/mL = 0.1 mL.   0.1 mL × 100 = 10 units.

The starting dose — just 10 units on the syringe.

Example 2 — semaglutide 0.5 mg @ 5 mg/mL

0.5 mg ÷ 5 mg/mL = 0.1 mL.   0.1 mL × 100 = 10 units.

Note: same 10 units as Example 1, but double the dose — because the vial is twice as strong.

Example 3 — semaglutide 1 mg @ 5 mg/mL

1 mg ÷ 5 mg/mL = 0.2 mL.   0.2 mL × 100 = 20 units.

A common maintenance dose draws to the 20-unit mark.

Example 4 — semaglutide 2.4 mg @ 8 mg/mL

2.4 mg ÷ 8 mg/mL = 0.3 mL.   0.3 mL × 100 = 30 units.

The top semaglutide weight-management dose, kept under a third of a syringe by a stronger vial.

Example 5 — tirzepatide 2.5 mg @ 10 mg/mL

2.5 mg ÷ 10 mg/mL = 0.25 mL.   0.25 mL × 100 = 25 units.

Tirzepatide's starting dose at a typical reconstitution — a quarter of the syringe.

Example 6 — tirzepatide 5 mg @ 10 mg/mL

5 mg ÷ 10 mg/mL = 0.5 mL.   0.5 mL × 100 = 50 units.

Exactly half a 1 mL syringe.

Example 7 — tirzepatide 5 mg @ 20 mg/mL

5 mg ÷ 20 mg/mL = 0.25 mL.   0.25 mL × 100 = 25 units.

Same 5 mg dose as Example 6, but a stronger vial halves the units to 25.

Example 8 — tirzepatide 10 mg @ 20 mg/mL

10 mg ÷ 20 mg/mL = 0.5 mL.   0.5 mL × 100 = 50 units.

A higher concentration keeps even 10 mg to a manageable half-syringe.

Example 9 — tirzepatide 15 mg @ 20 mg/mL

15 mg ÷ 20 mg/mL = 0.75 mL.   0.75 mL × 100 = 75 units.

The maximum tirzepatide dose draws to 75 units — three-quarters of the barrel.

Example 10 — when the draw is too big

tirzepatide 15 mg from a weak 10 mg/mL vial: 15 ÷ 10 = 1.5 mL × 100 = 150 units.

That exceeds a 1 mL syringe — a sign you need a more concentrated vial, not two injections.

GLP-1 dose-to-units conversion chart

Common weekly doses for semaglutide and tirzepatide, shown as U-100 syringe units at three concentrations you will actually see on compounded vials. A dash means the draw exceeds 1 mL at that concentration. Confirm every figure against your own vial label.

Weekly dose@ 2.5 mg/mL@ 5 mg/mL@ 10 mg/mL
0.25 mg (sema start)10 units5 units2.5 units
0.5 mg (sema)20 units10 units5 units
1 mg (sema)40 units20 units10 units
1.7 mg (sema)68 units34 units17 units
2.4 mg (sema max)96 units48 units24 units
2.5 mg (tirz start)100 units50 units25 units
5 mg (tirz)100 units50 units
7.5 mg (tirz)75 units
10 mg (tirz)100 units
12.5 mg (tirz)
15 mg (tirz max)

The cascade of dashes on the right shows why higher tirzepatide doses need higher-concentration vials: 12.5 mg and 15 mg both exceed 1 mL even at 10 mg/mL, so they are typically dispensed at 20 mg/mL or higher (15 mg → 75 units, as in Example 9). If your calculated draw is more than 100 units, your vial is too dilute for that dose — ask your pharmacy, do not split the dose across two jabs.

Common conversion mistakes

The maths is simple, but three errors account for most of the wrong draws people report:

  • Reading mg as units. A 2.5 mg dose is not 2.5 units. Milligrams and units are different quantities — you must run the conversion.
  • Using the wrong concentration. If you reconstituted the vial yourself with a different amount of water than the label assumed, the mg/mL changed, and so did every unit reading. See the related guide on why the water amount changes your units.
  • Forgetting the syringe is U-100. The ×100 step only holds for U-100 syringes. U-40 or U-50 syringes use different scales and are uncommon for these drugs, but if you have one, the multiplier changes.

Frequently asked questions

How do I convert mg to units for semaglutide or tirzepatide?

Divide your weekly milligram dose by the vial concentration in mg/mL to get millilitres, then multiply by 100. For example, 5 mg ÷ 10 mg/mL = 0.5 mL, and 0.5 mL × 100 = 50 units on a U-100 syringe.

Why does the same dose give different units on this chart?

Because units measure volume, not mass. A stronger vial packs the same milligrams into less liquid, so you draw fewer units. The dose into your body is identical; only the number of marks on the syringe changes.

What if my calculated draw is more than 100 units?

A standard 1 mL U-100 syringe only holds 100 units, so a larger result means your vial is too dilute for that dose. Use a higher-concentration vial rather than injecting twice. Confirm the right concentration with your prescriber or pharmacy.

Do semaglutide and tirzepatide use a different formula?

No. The conversion mg ÷ mg/mL × 100 = units is identical for both. They differ in their approved dose ranges and how they act in the body, but on the syringe they are just a mass dissolved in a volume.

Is this chart medical advice?

No. This is an education and maths reference, not medical advice. Doses, concentrations and titration are set by your prescriber, and you must always confirm the figures against your own vial label before injecting.

Sources

  1. WEGOVY (semaglutide injection) Prescribing Information — dose strengths and 0.25/0.5/1/1.7/2.4 mg titration (DailyMed / FDA label)
  2. ZEPBOUND (tirzepatide injection) Prescribing Information — 2.5/5/7.5/10/12.5/15 mg dose strengths (DailyMed / FDA label)
  3. OZEMPIC (semaglutide) injection Prescribing Information — weekly dosing and pen strengths (DailyMed / FDA label)
  4. MOUNJARO (tirzepatide) injection Prescribing Information — once-weekly dosing strengths (DailyMed / FDA label)
  5. U-100 insulin syringe: 100 units per 1 mL — unit-to-volume basis used throughout this chart (StatPearls, Insulin Administration, NCBI Bookshelf)
  6. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 2.4 mg maintenance dose (N Engl J Med 2021)
  7. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 5/10/15 mg doses (N Engl J Med 2022)
  8. Frias JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) (N Engl J Med 2021)
  9. Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) (N Engl J Med 2025)
  10. Smith HS, et al. Insulin syringe selection and U-100 dosing accuracy considerations (PMC)
  11. Farzam K, Patel P. Tirzepatide — dual GIP/GLP-1 agonist dosing and pharmacology (StatPearls, NCBI Bookshelf)
  12. Nauck MA, et al. GLP-1 receptor agonists in the treatment of type 2 diabetes — pharmacology overview (PMC)

This guide is for general educational purposes only and does not constitute medical advice. Always follow your prescriber’s specific instructions and consult a qualified clinician before changing any protocol.

Suggest